This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Lung Cancer
  • /
  • Molecular diagnostics and targeted therapies in no...
Journal

Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update

Read time: 1 mins
Published:27th Mar 2019
Author: Jonna S, Subramaniam DS.
Availability: Free full text
Ref.:Discov Med. 2019 Mar;27(148):167-170.
Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update


The understanding of genetic alterations that drive non-small cell lung cancer (NSCLC) is evolving. As many of these molecularly-defined subtypes are potentially actionable, new strategies in molecular diagnostics and targeted therapies in NSCLC to detect and treat them are being explored. At the International Association for Study of Lung Cancer 19th World Conference, several abstracts and oral presentations related to this topic. In this report, we discuss some of these updates.


Read abstract on library site  Access full article